Is the fatty acid desaturation index of blood lipids , as a biomarker of hepatic stearoyl-CoA desaturase expression , a predictive factor of breast cancer risk?
Epidemiological findings, in accordance with experimental data, suggested that decreased hepatic stearoyl-CoA desaturase expression/activity may be related to decreased risk of breast cancer.
These results show that, in node-negative patients, both tumor size and VEGF content predict for a reduced efficacy of postoperative radiotherapy as part of BCT, indicating that the choice of local treatment of these patients can also be modified based on tumor VEGF content.